Premium
Verapamil in the Management of Hypertensive Patients
Author(s) -
Lewis G. R. J.,
Morley K. D.,
Maslowski A. H.,
Bones P. J.
Publication year - 1979
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1979.tb04115.x
Subject(s) - verapamil , medicine , antihypertensive drug , blood pressure , drug , blockade , methyldopa , chemotherapy , anesthesia , pharmacology , calcium , receptor
Summary: The hypotensive action of verapamil given orally was assessed in the outpatient management of patients with raised blood pressure, in a single blind study. Twenty‐six hypertensive patients on no therapy, 14 on beta blockers and eight on methyldopa were more satisfactorily controlled when verapamil was substituted for the initial drug. There was a marked reduction in the number of side‐effects, and the drug was given in many situations where beta blockade was contra‐indicated.